NCAM1 and breast cancer: NCAM1, a marker known to be very high in activated cells and not just in NK cells (Van Acker, Capsomidis et al, 2017), was the top most differentially expressed gene in this clinically relevant BC γδ T-cell subtype (Fig 3H).